Shares of Opko Health Rise to a New 52-Week High
Opko Health (NYSE:OPK) traded at a new 52-week high today of $10.22. This new high was reached on above average trading volume as 9.4 million shares traded hands, while the average 30-day volume is approximately 4.1 million shares.
Opko Health (NYSE:OPK) is currently priced 1.5% above its average consensus analyst price target of $9.67. Opko Health shares have support at the 50-day moving average (MA) of $8.26 and additional support at the 200-day MA of $7.11.
Over the past year, Opko Health has traded in a range of $4.10 to $10.22 and is now at $9.81, 139% above that low. Over the past week, the 200-day moving average (MA) has gone up 1.0% while the 50-day MA has advanced 1.0%.
Opko Health, Inc. is a specialty pharmaceutical company that researches and develops pharmaceuticals. The Company researches treatments for macular degeneration and other ophthalmic diseases.
SmarTrend recommended that subscribers consider buying shares of Opko Health on June 18th, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $7.20. Since that recommendation, shares of Opko Health have risen 31.9%. We continue to monitor OPK for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows opko health